Burning Rock Biotech Accounts Payable

Burning Rock Biotech (BNR) currently reports a accounts payable of $18M as of March 2026. That compares with $36M in the prior-year period — down 49.8% year over year. Use the charts on this page to explore Burning Rock Biotech's accounts payable history and peer comparisons.

Burning Rock Biotech's accounts payable decreased from $36M to $18M — a 49.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Burning Rock Biotech reported $18M in accounts payable as of March 2026. That compares with $36M in the prior-year period — down 49.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $18M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Burning Rock Biotech, and consider following BNR for alerts when major investors trade the stock.

Burning Rock Biotech is classified in the Healthcare sector. On accounts payable, it currently shows $18M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BNR with unrelated industries.